G2TT
来源类型Report
规范类型报告
Provincial Drug Coverage for Vulnerable Canadians | Fraser Institute
其他题名Federal government risks ignoring existing provincial drug insurance plans in push for national program
Bacchus Barua; David Jacques; Nadeem Esmail
发表日期2018-10-16
出版年2018
语种英语
概述Provincial Drug Coverage for Vulnerable Canadians finds that every province already provides prescription drug coverage to help Canadians—particularly seniors and lower-income Canadians—pay for pharmaceuticals. Crucially, provinces are able to establish prescription drug plans to suit their particular priorities, population age, income levels and other factors, which differ from province to province. This customization would likely be lost or at least diluted if Canada adopts a national pharmacare program.
摘要

Access to pharmaceuticals is a critical component of a properly functioning health care system. The reality that some Canadians have difficulty paying for their medications, combined with unqualified claims regarding Canada’s approach towards drug coverage compared to its international peers has led to a perception that governments in Canada do not currently help Canadians— particularly vulnerable populations—pay for their prescription medications. Given the increasing importance and prominence of this public policy issue, an accurate understanding of existing provincial programs is critical.

First and perhaps most critically, a review of provincial drug plans finds extensive coverage for lower-income Canadians. Provinces, of course, differ with regards to their approach towards both general coverage and shared costs as well as how to support vulnerable groups like lower-income Canadians.

For example, British Columbia’s Fair PharmaCare plan, the province’s main drug coverage program, covers 70 percent of the cost of eligible prescription drugs for families with a net income less than $15,000. Once a family has spent approximately 2 percent of their net income on drugs or related costs, the province pays for 100 percent of any subsequent costs for the rest of the year. The province offers coverage to families with higher incomes but requires them to first pay out-of-pocket for their drug costs (up to 2–3 percent of their income) before any provincial coverage kicks in.

In Alberta, families (with children) earning less than $39,250 can access the province’s Non-Group coverage plan by paying a monthly premium of $82.60. Prescription drugs covered under the program are subject to a 30 percent co-payment up to a maximum of $25 per prescription. Higher-income families in Alberta can also access this program but with higher pre­miums. Lower-income Alberta families as well as a number of additional covered circumstances such as pregnancy, high ongoing prescription needs, and disability are exempted from premiums and any co-payments for many prescription drugs as well as some over-the-counter products. For example, a single parent with one child in Alberta with income less than approximately $26,000 would be exempt from the premium and co-pays under the Adult Health Benefit.

Quebec broadly has one of the more unique approaches to pharmaceutical coverage in Canada. It requires residents not covered by private group insurance to enroll in the government’s drug insurance plan (RAMQ). Participating individuals are required to pay premiums that range from $0 to $616 per year, depending on family income. Individuals must pay the first $19.90 of their drug costs out of pocket, after which they only pay 34.9 percent of the cost of eligible drugs up to a monthly maximum of $90.58 (after which all costs are covered). However, the premiums along with the deductibles and co-pays are waived for a host of different groups including Quebecers on social assistance, children under 18, full-time students, and persons with a functional impairment.

Ontario has three main programs to support its residents and their access to pharmaceuticals. The Ontario Drug Benefit Plan covers residents over the age of 65 plus those living in long-term care or special care homes, Ontarians on social assistance, and those with disabilities. Depending on income levels and circumstances, this program requires Ontarians to pay very low amounts upfront (ranging from $0–$100) before coverage begins, after which only small copayments (ranging from $2.00–$6.11) are required. This program was recently extended through the introduction of OHIP+ Children and Youth Pharmacare to cover youths under the age of 24—at no charge—who are not currently cov­ered by private plans. Ontario also maintains the Trillium Drug Plan, which covers non-senior adults and those not generally covered by the other two pro­grams. The costs of the program vary by household type and income.

More generally, lower-income Canadians have access to at least some form of provincial insurance that helps limit out-of-pocket costs for prescription drugs to a small percentage of income, if not more extensive coverage, in every Canadian province.

It’s worthwhile also noting that recipients of social assistance have coverage at very low or even zero cost in every province. Provincial governments across Canada also provide drug coverage to select populations who may face considerable hardships as a result of either their medical care costs or other factors including the severely disabled and those diagnosed with conditions like multiple sclerosis and cystic fibrosis.

The review also finds that every province maintains a drug coverage program for seniors. While there are differences in the income thresholds for accessing public coverage, coverage for seniors tends to be relatively more generous than for non-senior adults without children.

The importance of prescription medicines paired with concerns about their affordability for those stricken with illness form the basis of many calls for a national pharmacare plan. Lacking in the debate is a clear understanding of the coverage that is already available to those subsets of the Canadian population who may be at higher risk of foregoing their prescriptions due to cost—i.e., those with lower incomes (including seniors), the disabled, and patients with chronic medical conditions.

URLhttps://www.fraserinstitute.org/studies/provincial-drug-coverage-for-vulnerable-canadians
来源智库Fraser Institute (Canada)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/462234
推荐引用方式
GB/T 7714
Bacchus Barua,David Jacques,Nadeem Esmail. Provincial Drug Coverage for Vulnerable Canadians | Fraser Institute. 2018.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
provincial-drug-cove(198KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bacchus Barua]的文章
[David Jacques]的文章
[Nadeem Esmail]的文章
百度学术
百度学术中相似的文章
[Bacchus Barua]的文章
[David Jacques]的文章
[Nadeem Esmail]的文章
必应学术
必应学术中相似的文章
[Bacchus Barua]的文章
[David Jacques]的文章
[Nadeem Esmail]的文章
相关权益政策
暂无数据
收藏/分享
文件名: provincial-drug-coverage-for-vulnerable-canadians-execsumm.pdf
格式: Adobe PDF

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。